RAREUltragenyx Pharmaceutical Inc.May 6, 2026Q1 2026
Read transcript →Ultragenyx Pharmaceutical Inc. (RARE) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$27.38
+10.34%
Mkt Cap $2.26B
RAREUltragenyx Pharmaceutical Inc.May 6, 2026RAREUltragenyx Pharmaceutical Inc.Feb 12, 2026Q4 2025
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 5, 2025Q3 2025
Read transcript →RAREUltragenyx Pharmaceutical Inc.Aug 6, 2025Q2 2025
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 6, 2025Q1 2025
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 13, 2025Q4 2024
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 5, 2024Q3 2024
Read transcript →RAREUltragenyx Pharmaceutical Inc.Aug 2, 2024Q2 2024
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 2, 2024Q1 2024
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 15, 2024Q4 2023
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 2, 2023Q3 2023
Read transcript →RAREUltragenyx Pharmaceutical Inc.Aug 3, 2023Q2 2023
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 4, 2023Q1 2023
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 16, 2023Q4 2022
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 2, 2022Q3 2022
Read transcript →RAREUltragenyx Pharmaceutical Inc.Jul 29, 2022Q2 2022
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 5, 2022Q1 2022
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 10, 2022Q4 2021
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 2, 2021Q3 2021
Read transcript →RAREUltragenyx Pharmaceutical Inc.Aug 3, 2021Q2 2021
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 5, 2021Q1 2021
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 11, 2021Q4 2020
Read transcript →RAREUltragenyx Pharmaceutical Inc.Oct 28, 2020Q3 2020
Read transcript →RAREUltragenyx Pharmaceutical Inc.Jul 31, 2020Q2 2020
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 7, 2020Q1 2020
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 14, 2020Q4 2019
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 6, 2019Q3 2019
Read transcript →RAREUltragenyx Pharmaceutical Inc.Aug 2, 2019Q2 2019
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 7, 2019Q1 2019
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 19, 2019Q4 2018
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 6, 2018Q3 2018
Read transcript →RAREUltragenyx Pharmaceutical Inc.Aug 2, 2018Q2 2018
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 7, 2018Q1 2018
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 21, 2018Q4 2017
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 5, 2017Q3 2017
Read transcript →RAREUltragenyx Pharmaceutical Inc.Jul 27, 2017Q2 2017
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 5, 2017Q1 2017
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 16, 2017Q4 2016
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 7, 2016Q3 2016
Read transcript →RAREUltragenyx Pharmaceutical Inc.Aug 9, 2016Q2 2016
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 9, 2016Q1 2016
Read transcript →RAREUltragenyx Pharmaceutical Inc.Feb 26, 2016Q4 2015
Read transcript →RAREUltragenyx Pharmaceutical Inc.Nov 9, 2015Q3 2015
Read transcript →RAREUltragenyx Pharmaceutical Inc.Aug 13, 2015Q2 2015
Read transcript →RAREUltragenyx Pharmaceutical Inc.May 11, 2015Q1 2015
Read transcript →RAREUltragenyx Pharmaceutical Inc.Mar 25, 2015Q4 2014
Read transcript →